June 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biomea Fusion, GE Aerospace and P&G on Tuesday.
HIGHLIGHTS
* Biomea Fusion Inc BMEA.O: Piper Sandler assumes coverage with target price $7 |
* CVS Health CVS.N: Barclays cuts target price to $79 from $82 |
* GE Aerospace GE.N: RBC raises target price to $275 from $220 |
* Netflix Inc NFLX.O: Jefferies raises target price to $1400 from $1200 |
* P&G PG.N: Berenberg cuts target price to $152 from $157 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Applied Digital Corp APLD.O: Needham raises target price to $12 from $10 |
* Applovin Corp APP.O: JP Morgan raises target price to $400 from $355 |
* Asgn Inc ASGN.N: Wells Fargo initiates coverage with equal weight rating; PT $56 |
* Axsome Therapeutics AXSM.O: Oppenheimer initiates coverage with outperform rating |
* Axsome Therapeutics AXSM.O: Oppenheimer initiates coverage with PT $185 |
* Badger Meter BMI.N: Raymond James initiates coverage with market perform rating |
* Biomea Fusion Inc BMEA.O: Piper Sandler assumes coverage with overweight rating |
* Biomea Fusion Inc BMEA.O: Piper Sandler assumes coverage with target price $7 |
* Biontech SE BNTX.O: Truist Securities raises target price to $155 from $151 |
* Block XYZ.N: Evercore ISI raises to outperform from in line; ups PT to $75 from $58 |
* Block XYZ.N: Jefferies raises target price to $75 from $70 |
* Block XYZ.N: Truist Securities raises target price to $61 from $60 |
* Blueprint Medicines Corp BPMC.O: JP Morgan cuts target price to $129 from $130 |
* Blueprint Medicines Corp BPMC.O: JP Morgan cuts to neutral from overweight |
* Blueprint Medicines Corp BPMC.O: Stephens cuts target price to $135 from $150 |
* Blueprint Medicines Corp BPMC.O: Stephens cuts to equal-weight from overweight |
* Blueprint Medicines Corp BPMC.O: TD Cowen cuts to hold from buy |
* Broadcom Inc AVGO.O: Citigroup raises target price to $276 from $210 |
* Brown-Forman Corp BFb.N: Bernstein cuts target price to $53 from $57.5 |
* Bumble Inc BMBL.O: JP Morgan cuts to underweight from neutral |
* Campbell's Co CPB.O: Bernstein cuts target price to $44 from $47 |
* Campbell's Co CPB.O: Deutsche Bank cuts target price to $35 from $39 |
* Campbell's Co CPB.O: Morgan Stanley cuts target price to $35 from $40 |
* Campbell's Co CPB.O: Piper Sandler cuts target price to $41 from $42 |
* Campbell's Co CPB.O: RBC cuts target price to $38 from $44 |
* Campbell's Co CPB.O: Stifel cuts target price to $38 from $40 |
* Camping World Holdings Inc CWH.N: Truist Securities raises PT to $20 from $16 |
* Cardinal Health Inc CAH.N: Leerink Partners raises target price to $177 from $173 |
* Cardinal Health Inc CAH.N: Wells Fargo raises target price to $179 from $136 |
* Cardinal Health Inc CAH.N: Wells Fargo raises to overweight from equal weight |
* Cencora COR.N: Wells Fargo raises target price to $337 from $274 |
* Cencora COR.N: Wells Fargo raises to overweight from equal weight |
* Centene CNC.N: Barclays cuts target price to $65 from $84 |
* Centene CNC.N: Barclays cuts to equal-weight from overweight |
* Chewy CHWY.N: Deutsche Bank raises target price to $38 from $27 |
* Ciena Corp CIEN.N: Rosenblatt Securities raises target price to $85 from $65 |
* Cigna CI.N: Barclays raises target price to $385 from $382 |
* Coherent Corp COHR.N: Citigroup raises target price to $115 from $110 |
* Crowdstrike CRWD.O: Wedbush raises target price to $525 from $475 |
* CVS Health CVS.N: Barclays cuts target price to $79 from $82 |
* Digitalbridge Group Inc DBRG.N: Truist Securities raises target price to $15 from $13 |
* Disney DIS.N: Rosenblatt Securities raises target price to $140 from $135 |
* Elevance Health Inc ELV.N: Barclays cuts target price to $480 from $522 |
* Fedex Corp FDX.N: Barclays cuts target price to $330 from $350 |
* Five Below Inc FIVE.O: Mizuho raises target price to $100 from $88 |
* Fortive Corporation FTV.N: Barclays raises target price to $86 from $84 |
* Frontdoor Inc FTDR.O: JP Morgan raises target price to $55 from $50 |
* GE Aerospace GE.N: RBC raises target price to $275 from $220 |
* Greif Inc GEF.N: Wells Fargo cuts target price to $67 from $75 |
* HCA Healthcare Inc HCA.N: Barclays raises target price to $416 from $366 |
* Humana HUM.N: Barclays cuts target price to $273 from $322 |
* Immunic Inc IMUX.O: Leerink Partners cuts target price to $4 from $6 |
* KB Home KBH.N: Wells Fargo cuts target price to $53 from $55 |
* Kinder Morgan Inc KMI.N: Stifel raises target price to $28 from $27 |
* Kymera Therapeutics Inc KYMR.O: B. Riley raises target price to $60 from $38 |
* Kymera Therapeutics Inc KYMR.O: B. Riley raises to buy from neutral |
* Kymera Therapeutics Inc KYMR.O: BofA Global Research raises PT $51 from $44 |
* Kymera Therapeutics Inc KYMR.O: BofA Global Research raises to buy from neutral |
* Kymera Therapeutics Inc KYMR.O: Citigroup raises target price to $60 from $52 |
* Kymera Therapeutics Inc KYMR.O: Guggenheim raises target price to $60 from $52 |
* Kymera Therapeutics Inc KYMR.O: Morgan Stanley raises PT to $79 from $49 |
* Kymera Therapeutics Inc KYMR.O: Morgan Stanley raises to overweight from equal-weight |
* LCI Industries LCII.N: Truist Securities raises target price to $88 from $80 |
* McKesson Corp MCK.N: Wells Fargo raises target price to $766 from $691 |
* Molina Healthcare MOH.N: Barclays cuts target price to $351 from $362 |
* Netflix Inc NFLX.O: Jefferies raises target price to $1400 from $1200 |
* ONEOK Inc OKE.N: Barclays cuts target price to $91 from $101 |
* Oshkosh OSK.N: Truist Securities raises to buy from hold; ups PT to $127 from $93 |
* P&G PG.N: Berenberg cuts target price to $152 from $157 |
* Parsons Corp PSN.N: BofA Global Research cuts price objective to $95 from $100 |
* Patrick Industries Inc PATK.O: Truist Securities raises PT to $105 from $100 |
* Peakstone Realty Trust PKST.N: Truist Securities raises target price to $16 from $15 |
* Pennant Group Inc PNTG.O: Wells Fargo raises target price to $31 from $30 |
* Perspective Therapeutics Inc CATX.A: RBC raises target price to $16 from $15 |
* Pinterest PINS.N: JP Morgan raises to overweight from neutral; ups PT to $40 from $35 |
* Prairie Operating Co PROP.O: Citigroup initiates coverage with buy rating; PT $8 |
* Resideo Technologies Inc REZI.N: JP Morgan raises target price to $21 from $20 |
* Roblox Corp RBLX.N: JP Morgan raises target price to $100 from $80 |
* Rocket Lab USA Inc RKLB.O: Deutsche Bank raises target price to $27 from $24 |
* Roku Inc ROKU.O: JP Morgan raises target price to $85 from $75 |
* Sailpoint Inc SAIL.O: Barclays cuts target price to $23 from $27 |
* Science Applications International SAIC.O: Truist Securities cuts PT to $100 from $115 |
* Science Applications International SAIC.O: Citigroup cuts PT to $144 from $155 |
* Sun Communities Inc SUI.N: Truist Securities raises target price to $137 from $135 |
* Tenet Healthcare Inc THC.N: Barclays raises target price to $215 from $171 |
* Thor Industries Inc THO.N: Truist Securities raises target price to $78 from $72 |
* Toll Brothers Inc TOL.N: Wells Fargo cuts target price to $125 from $130 |
* Trevi Therapeutics Inc TRVI.O: Oppenheimer raises target price to $23 from $20 |
* UnitedHealth UNH.N: Barclays cuts target price to $350 from $362 |
* UnitedHealth UNH.N: Piper Sandler cuts target price to $353 from $552 |
* Uranium Energy UEC.A: BMO initiates coverage with outperform rating; PT $7.75 |
* Veeva Systems Inc VEEV.N: Mizuho raises target price to $295 from $280 |
* Vera Therapeutics Inc VERA.O: Guggenheim raises target price to $65 from $61 |
* $Vornado Realty Trust(VNO-N)$ VNO.N: Truist Securities raises target price to $38 from $37 |
* Winnebago Industries Inc WGO.N: Truist Securities raises PT to $40 from $38 |
* Woodward WWD.O: Deutsche Bank raises target price to $291 from $196 |
* Woodward WWD.O: Deutsche Bank raises to buy from hold |
* Xometry Inc XMTR.O: JP Morgan raises target price to $38 from $36 |
* Zoominfo Technologies Inc GTM.O: Jefferies cuts target price to $14 from $15 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。